Article
Living with Transthyretin amyloid cardiomyopathy from a patient perspective.
BMC cardiovascular disorders - 12 Nov 2025
Bui Quan M, McCain Julia, Allen Larry A, Adler Eric D, Anderson Cheryl, Bloss Cinnamon, Rabin Borsika A, Urey Marcus A
Abstract excerpt
BACKGROUND: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive condition for which disease-modifying therapies are increasingly available. However, limited research has explored the patient experience with ATTR-CM and its impact on quality of life. METHODS: In this single-center qualitative study, we conducted semi-structured interviews with ten participants (either with ATTR-CM or at-risk family...
Topics
Join the communities discussing this publication.
